IMDZ Snapped Up, NVRO Falls On Dim Outlook, OPNT Ceases Bulimia Nervosa Trial

Today’s Daily Dose brings you news about Exact Sciences’ better-than-expected Q4 financial results; Merck’s acquisition of Immune Design; Nevro’s lackluster revenue outlook; Opiant Pharma’ s disappointing Bulimia Nervosa study results; and near-term catalyst of Zosano Pharma. Read on… Exact Sciences Corp. (EXAS) has reported better-than-expected financial results for the fourth […]

» Read more

Billionaire Elon Musk Lauds Bitcoin As "Quite Brilliant," Why Isn't Tesla Going Crypto?

While Elon Musk has yet to formally delve into the Bitcoin space, he has long been a fabled member of the crypto community. Since finding his way to the headlines of the world’s media, the Tesla chief executive’s pro-innovation mindset has struck a chord with many enamored with cryptocurrencies. In […]

» Read more

Bitcoin is decentralized and the ledger is correct but the structure is inefficient, says Bank of Canada

Bitcoin [BTC] and other cryptocurrencies have been considered revolutionary in the finance and technology industry. Moreover, Bitcoin, currently the largest cryptocurrency in the space and also the very first cryptocurrency, is often hailed as digital gold, and a currency that would give financial freedom to all. The topic of whether […]

» Read more
1 2 3 124